Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CNC 
Centene Corp (CNC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/13/2025: CNC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
19 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $34.56
1 Year Target Price $34.56
| 7 | Strong Buy |
| 3 | Buy |
| 9 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -21.88% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/13/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 13.29B USD | Price to earnings Ratio 6.57 | 1Y Target Price 34.56 |
Price to earnings Ratio 6.57 | 1Y Target Price 34.56 | ||
Volume (30-day avg) 19 | Beta 0.4 | 52 Weeks Range 25.08 - 80.59 | Updated Date 08/13/2025 |
52 Weeks Range 25.08 - 80.59 | Updated Date 08/13/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 4.12 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-07-24 | When Before Market | Estimate 2.02 | Actual -0.16 |
Profitability
Profit Margin 1.29% | Operating Margin (TTM) -0.07% |
Management Effectiveness
Return on Assets (TTM) 2.5% | Return on Equity (TTM) 7.44% |
Valuation
Trailing PE 6.57 | Forward PE 13.21 | Enterprise Value 13148950610 | Price to Sales(TTM) 0.08 |
Enterprise Value 13148950610 | Price to Sales(TTM) 0.08 | ||
Enterprise Value to Revenue 0.07 | Enterprise Value to EBITDA 2.8 | Shares Outstanding 491132992 | Shares Floating 463438010 |
Shares Outstanding 491132992 | Shares Floating 463438010 | ||
Percent Insiders 0.46 | Percent Institutions 101.58 |
Upturn AI SWOT
Centene Corp
Company Overview
History and Background
Centene Corp. was founded in 1984 as a managed care organization focusing on government-sponsored healthcare programs. It has grown through acquisitions and organic expansion to become a major player in the health insurance industry.
Core Business Areas
- Managed Care: Centene's core business involves providing managed care services primarily through Medicaid, Medicare, and the Health Insurance Marketplace. They offer health plans and related services to individuals, families, and employers.
- Specialty Services: This segment includes pharmacy benefit management (PBM), behavioral health, vision, dental, and other specialty healthcare services provided to members and external clients.
- Healthcare Enterprise: Formerly known as Magellan Health, this provides behavioral health and specialty healthcare solutions. It includes government and commercial segments.
Leadership and Structure
Centene Corp. is led by a Board of Directors and a senior management team. Sarah M. London is the current Chief Executive Officer. The organizational structure is designed to support its diverse business segments and geographic reach.
Top Products and Market Share
Key Offerings
- Medicaid Managed Care: Centene provides managed care services to Medicaid beneficiaries. Centene is one of the largest Medicaid managed care organizations in the U.S. Competitors include UnitedHealth Group (UNH), Elevance Health (ELV), and Molina Healthcare (MOH).
- Medicare Advantage: Centene offers Medicare Advantage plans to eligible seniors and individuals with disabilities. Market share data varies by region, but Centene holds a significant position. Competitors include UnitedHealth Group (UNH), Humana (HUM), and CVS Health (CVS).
- Health Insurance Marketplace: Centene participates in the Health Insurance Marketplace, offering individual and family health plans. Competitors include UnitedHealth Group (UNH), Elevance Health (ELV), and Cigna (CI).
- Pharmacy Benefit Management (PBM): Centene, through its Envolve Pharmacy Solutions, offers PBM services. Competitors include CVS Health (CVS) and UnitedHealth Group (UNH).
Market Dynamics
Industry Overview
The managed care industry is characterized by intense competition, increasing regulatory scrutiny, and evolving healthcare landscape influenced by factors like government policies, technological advancements, and changing consumer preferences.
Positioning
Centene is a leading provider of managed care services, particularly in the government-sponsored healthcare market. Its competitive advantages include its scale, expertise in Medicaid, and focus on underserved populations.
Total Addressable Market (TAM)
The total addressable market for managed care in the U.S. is estimated to be in the trillions of dollars annually. Centene is positioned to capture a significant portion of this market through its various offerings and geographic reach.
Upturn SWOT Analysis
Strengths
- Large Scale and Market Share
- Expertise in Government-Sponsored Healthcare Programs
- Strong Relationships with State Governments
- Diverse Product Portfolio
- Extensive Geographic Reach
Weaknesses
- Reliance on Government Funding and Regulatory Changes
- High Debt Levels
- Integration Challenges with Acquisitions
- Sensitivity to Healthcare Policy Changes
Opportunities
- Expansion into New Geographic Markets
- Growth in Medicare Advantage Enrollment
- Strategic Acquisitions and Partnerships
- Increased Demand for Value-Based Care
- Growth in Specialty Services
Threats
- Changes in Government Healthcare Policies
- Increased Competition
- Rising Healthcare Costs
- Cybersecurity Risks
- Economic Downturn
Competitors and Market Share
Key Competitors
- UNH
- ELV
- HUM
- MOH
Competitive Landscape
Centene's advantages include its focus on government-sponsored programs and its expertise in managing complex populations. Disadvantages include reliance on government funding and competitive pressures from larger, more diversified players.
Major Acquisitions
WellCare Health Plans
- Year: 2020
- Acquisition Price (USD millions): 17300
- Strategic Rationale: Expanded Centene's Medicare and Medicaid presence and geographic footprint.
Magellan Health
- Year: 2022
- Acquisition Price (USD millions): 9500
- Strategic Rationale: Broadened Centene's behavioral health and specialty healthcare capabilities.
Growth Trajectory and Initiatives
Historical Growth: Centene has experienced significant growth through acquisitions and organic expansion, particularly in government-sponsored healthcare programs.
Future Projections: Analysts project continued growth for Centene, driven by increasing enrollment in Medicaid and Medicare Advantage, and expansion into new markets. Growth rates are subject to change based on market conditions and regulatory factors.
Recent Initiatives: Centene has focused on strategic acquisitions, investments in technology and innovation, and expansion of its specialty services offerings.
Summary
Centene Corp is a major player in the managed care sector with a strong focus on government-sponsored programs. Their acquisitions have strengthened their market position and expanded their offerings. A potential weakness is their reliance on government funding, as well as the need to watch out for increased competition and healthcare cost fluctuations. Their growth prospects are promising, driven by increased enrollment in Medicare and Medicaid programs.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Investor Relations Materials
- Analyst Reports
- Industry Publications
- Company Website
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor. Market share estimates are approximate and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Centene Corp
Exchange NYSE | Headquaters Saint Louis, MO, United States | ||
IPO Launch date 2001-12-13 | CEO & Director Ms. Sarah M. London | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 60500 | Website https://www.centene.com |
Full time employees 60500 | Website https://www.centene.com | ||
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.